195 related articles for article (PubMed ID: 35134736)
1. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.
Reddy YM; Yeduguri S; Reddy N VS; Parida S; Kamatham SN; Pidaparthi L; Jaiswal SK; Sadhvani B; Tourani V; Kumar S; Challa S; Murthy JM
J Mycol Med; 2022 May; 32(2):101252. PubMed ID: 35134736
[TBL] [Abstract][Full Text] [Related]
2. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
[TBL] [Abstract][Full Text] [Related]
9. Covid-19-associated rhino-orbito-cerebral mucormycosis (CAROM) in Delhi: Demographics and risk factors in a single-centre consecutive cohort of 200 inpatients.
Singh A; Sikka K; Goel G; Kanodia A; Chandran A; Konkimalla A; Panda S; Garg RK; Xess I; Tandon N; Thakar A
Natl Med J India; 2022; 35(3):132-137. PubMed ID: 36461870
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
14. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
15. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
Kumar S; Choudhary R; Pandey VP
J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
[TBL] [Abstract][Full Text] [Related]
17. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus Disease 2019 (COVID-19)-Associated Rhino-Orbito-Cerebral Mucormycosis: A Multi-Institutional Retrospective Study of Imaging Patterns.
Kumar Gg S; Deepalam S; Siddiqui A; Adiga CP; Kumar S; Shivalingappa SS; Acharya UV; Goolahally LN; Sharma S; Andrew D; Hosmani P; Nair S; Medikeri G; Rao RM; Agadi JB; Kumar S; Adoor G; Sharma S; Hegde R; Saini J; Kulanthaivelu K
World Neurosurg; 2022 Jun; 162():e131-e140. PubMed ID: 35257953
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated mucormycosis: Case report and systematic review.
Dilek A; Ozaras R; Ozkaya S; Sunbul M; Sen EI; Leblebicioglu H
Travel Med Infect Dis; 2021; 44():102148. PubMed ID: 34454090
[TBL] [Abstract][Full Text] [Related]
20. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
